Literature DB >> 26435486

Robot-assisted partial nephrectomy with intracorporeal renal hypothermia using ice slush: step-by-step technique and matched comparison with warm ischaemia.

Daniel Ramirez1, Peter A Caputo1, Jayram Krishnan1, Homayoun Zargar1,2, Jihad H Kaouk1.   

Abstract

OBJECTIVES: To outline our step-by-step technique for intracorporeal renal cooling during robot-assisted partial nephrectomy (RAPN). PATIENTS AND METHODS: Patient selection was performed during a preoperative clinic visit. Cases where we estimated during preoperative assessment that warm ischaemia time would be >30 min, as determined by whether the patient had a complex renal mass, were selected. The special equipment required for this procedure includes an Ecolab Hush Slush machine (Microtek Medical Inc., Columbus, MS, USA) a Mon-a-therm needle thermocouple device (Covidien, Mansfield, MA, USA) and six modified 20-mL syringes. Patients are arranged in a 60° modified flank position with the operating table flexed slightly at the level of the anterior superior iliac spine. For the introduction of a temperature probe and ice slush, an additional 12-mm trocar is placed along the mid-axillary line beneath the costal margin. Modified 10/20 mL syringes are prefilled with ice slush for instillation via an accessory trocar. Peri-operative and 6-month functional outcomes in the cold ischaemia group were compared with those of a cohort of patients who underwent RAPN with warm ischaemia in a 2:1 matched fashion. Matching was performed based on preoperative estimated glomerular filtration rate (GFR), ischaemia time and RENAL nephrometry score.
RESULTS: Strategies for successful intracorporeal renal cooling include: (i) placement of accessory port directly over the kidney; (ii) uniform ice consistency and modified syringes; (iii) sequential clamping of renal artery and vein; (iv) protection of the neighbouring intestine with a laparoscopic sponge; and (v) complete mobilization of the kidney. Kidney temperature is monitored via a needle thermocoupler device, while core body temperature is concurrently monitored via an oesophageal probe in real time. Renal function was assessed by serum creatinine level, estimated GFR (eGFR) and mercaptoacetyltriglycine (MAG-3) renal scan, peri-operatively and at 6-month follow-up. In the separate matched analysis, cold ischaemia during RAPN was found to be associated with a 12.9% improvement in preservation of postoperative eGFR. No difference was seen in either group at 6-month follow-up.
CONCLUSIONS: We conclude that RAPN with intracorporeal renal hypothermia using ice slush is technically feasible and may improve postoperative renal function in the short term. Our technique for intracorporeal hypotheramia is cost-effective, simple and highly reproducible.
© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  nephron-sparing surgery; partial nephrectomy; renal hypothermia; robotic surgery

Mesh:

Substances:

Year:  2015        PMID: 26435486     DOI: 10.1111/bju.13346

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

Review 1.  Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass.

Authors:  John Withington; Joana B Neves; Ravi Barod
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

Review 2.  Frontiers in robot-assisted retroperitoneal oncological surgery.

Authors:  Wesley W Ludwig; Michael A Gorin; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

3.  Effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy: a randomized trial.

Authors:  Bora Lee; Sook Young Lee; Na Young Kim; Koon Ho Rha; Young Deuk Choi; Sujung Park; So Yeon Kim
Journal:  Surg Endosc       Date:  2017-06-07       Impact factor: 4.584

4.  Robotic and open partial nephrectomy for localized renal tumors larger than 7 cm: a single-center experience.

Authors:  Ercan Malkoc; Daniel Ramirez; Onder Kara; Matthew J Maurice; Ryan J Nelson; Peter A Caputo; Jihad H Kaouk
Journal:  World J Urol       Date:  2016-09-23       Impact factor: 4.226

Review 5.  Current Status of Minimally Invasive Surgery for Renal Cell Carcinoma.

Authors:  Zachary L Smith
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

6.  A propensity score-matched comparison of surgical precision obtained by using volumetric analysis between robot-assisted laparoscopic and open partial nephrectomy for T1 renal cell carcinoma: a retrospective non-randomized observational study of initial outcomes.

Authors:  Toshio Takagi; Tsunenori Kondo; Hidekazu Tachibana; Junpei Iizuka; Kenji Omae; Hirohito Kobayashi; Kazuhiko Yoshida; Yasunobu Hashimoto; Kazunari Tanabe
Journal:  Int Urol Nephrol       Date:  2016-06-04       Impact factor: 2.370

7.  Intracorporeal renal hypothermia with ice slush for robot-assisted partial nephrectomy in a highly complex renal mass.

Authors:  José Luis Bauza; Prithvi Murthy; Daniel Sagalovich; Riccardo Bertolo; Enrique Pieras; Pedro Piza; Jihad Kaouk
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

8.  Editorial Comment: Off-clamp robotic-assisted partial nephrectomy.

Authors:  Mike Bozin; Homayoun Zargar
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

9.  Robotic cold ischemia achieves comparable functional outcomes to open cold ischemia during partial nephrectomy for complex kidney tumors.

Authors:  Ryan J Nelson; Julien Dagenais; Matthew J Maurice; Jaya Sai S Chavalia; Daniel Ramirez; Peter A Caputo; Paurush Babbar; Nitin K Yerram; Jihad H Kaouk
Journal:  Urol Ann       Date:  2018 Oct-Dec

10.  Robotic-assisted partial nephrectomy with sequential clamping of segmental renal arteries for multiple ipsilateral renal tumors: initial outcomes.

Authors:  Jie Yang; Jia-Dong Xia; Jian-Xin Xue; Ning-Hong Song; Chao Liang; Di Xi; Ya-Min Wang; Zeng-Jun Wang
Journal:  BMC Urol       Date:  2019-05-03       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.